Isnani, Ayang .
HRN: 26-05-21 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
CEFUROXIME 1.5GM (VIAL)
10/15/2024
10/16/2024
IV
1.5g
PTOR
Elective CS
Waiting Final Action
10/15/2024
CEFUROXIME 500MG (TAB)
10/15/2024
10/22/2024
PO
500mg
BID
S/P LTCS
Waiting Final Action
10/15/2024
MUPIROCIN 2%, 15G (TUBE)
10/15/2024
10/20/2024
TOPICAL
2%
BID
S/P LTCS
Waiting Final Action